◆英語タイトル:Daxor Corp (DXR) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C2997
◆発行会社(調査会社):
GlobalData
◆発行日:2018年8月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Daxor Corp (DXR) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Daxor Corp (Daxor) is a biotechnology company that offers original medical equipment for medical personnel. The company manufactures blood volume analyzers. Its flagship product, BVA-100 blood volume analyzer is an instrument to measure human blood volume. The product is used in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit. It finds application in a range of medical and surgical conditions such as congestive heart failure, intensive care unit medicine, critical care medicine, syncope, hypertension, pre-operative blood screening for hidden anemia, kidney failure, anemia in cancer patients, red cell mass test, hyponatremia and other conditions. The company offers its product to hospitals and clinics and physicians. Daxor is headquartered in New York, the US.
Daxor Corp Key Recent Developments
Jun 12,2018: Daxor Names Kathryn A. Kornafel As Vice President Of Marketing And Commercial Development
Mar 22,2018: Daxor to Exhibit at the American Association of Heart Failure Nurses 2018 Advanced Heart Failure Symposium
Mar 14,2018: New Data Showing Patient Care Individualized by Daxor’s Precision Blood Volume Analysis Reduces Heart Failure
May 31,2017: Daxor Announces Hiring of Chief Financial Officer
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Daxor Corp – Key Facts 5
Daxor Corp – Key Employees 6
Daxor Corp – Key Employee Biographies 7
Daxor Corp – Major Products and Services 8
Daxor Corp – History 9
Daxor Corp – Company Statement 12
Daxor Corp – Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Section 2 – Company Analysis 14
Company Overview 14
Daxor Corp – Business Description 15
Daxor Corp – Corporate Strategy 16
Daxor Corp – SWOT Analysis 17
SWOT Analysis – Overview 17
Daxor Corp – Strengths 17
Daxor Corp – Weaknesses 18
Daxor Corp – Opportunities 19
Daxor Corp – Threats 20
Daxor Corp – Key Competitors 21
Section 3 – Company Financial Ratios 22
Financial Ratios – Capital Market Ratios 22
Financial Ratios – Annual Ratios 23
Performance Chart 25
Financial Performance 25
Financial Ratios – Interim Ratios 26
Financial Ratios – Ratio Charts 27
Section 4 – Company’s Lifesciences Financial Deals and Alliances 28
Daxor Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 28
Daxor Corp, Medical Equipment, Deals By Type, 2012 to YTD 2018 29
Daxor Corp, Recent Deals Summary 30
Section 5 – Company’s Recent Developments 31
Jun 12, 2018: Daxor Names Kathryn A. Kornafel As Vice President Of Marketing And Commercial Development 31
May 31, 2017: Daxor Announces Hiring of Chief Financial Officer 32
Section 6 – Appendix 33
Methodology 33
Ratio Definitions 33
About GlobalData 37
Contact Us 37
Disclaimer 37
List of Tables
Daxor Corp, Key Facts 5
Daxor Corp, Key Employees 6
Daxor Corp, Key Employee Biographies 7
Daxor Corp, Major Products and Services 8
Daxor Corp, History 9
Daxor Corp, Subsidiaries 13
Daxor Corp, Key Competitors 21
Daxor Corp, Ratios based on current share price 22
Daxor Corp, Annual Ratios 23
Daxor Corp, Annual Ratios (Cont...1) 24
Daxor Corp, Interim Ratios 26
Daxor Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 28
Daxor Corp, Medical Equipment, Deals By Type, 2012 to YTD 2018 29
Daxor Corp, Recent Deals Summary 30
Currency Codes 33
Capital Market Ratios 33
Equity Ratios 34
Profitability Ratios 34
Cost Ratios 35
Liquidity Ratios 35
Leverage Ratios 36
Efficiency Ratios 36
List of Figures
Daxor Corp, Performance Chart (2013 - 2017) 25
Daxor Corp, Ratio Charts 27
Daxor Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 28
Daxor Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 29